Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

UroGen Pharma Ltd. , a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.

52W Range

77thpctl

Volume

1.62×avg

Market Cap

2.08BUSD

P/E Ratio

-21.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

UroGen Pharma Ltd.

URGNNASDAQ·USD·Closed

UroGen Pharma Ltd.

URGNNASDAQ·USD·Closed

$42.78

+3.33%

$42.78

+$1.38 (3.33%)

52W Range

77thpctl

Volume

1.62×avg

Mkt Cap

2.08BUSD

P/E

-21.6TTM

Div Yield

–ann

URGN: UroGen Pharma Ltd. Stock Analysis | finqOS